The 7 analysts offering 12-month price forecasts for Sutro Biopharma Inc have a median target of 19.00, with a high estimate of 23.00 and a low estimate of 16.00. The median estimate represents a +83.40% increase from the last price of 10.36.
The current consensus among 8 polled investment analysts is to Buy stock in Sutro Biopharma Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.70
Reporting Date Apr 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.